Dragotakes Consulting is categorized under Pharmaceutical Machinery Manufacturers in Medfield, MA and active since 1991.
Dragotakes Consulting was established in 1991, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Stephen Dragotakes at the company’s single location by writing to 18 Hillcrest Road, Medfield, Massachusetts MA 02052 or by phoning (508) 359-7214. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dragotakes Consulting |
Contact Person: | Stephen Dragotakes |
Address: | 18 Hillcrest Road, Medfield, Massachusetts 02052 |
Phone Number: | (508) 359-7214 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1991 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Pharmaceutical Machinery Manufacturers |
SIC Code: | 3559 |
NAICS Code: | 333249 |
Share This Business: |
Dragotakes Consulting was started in 1991 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephen Dragotakes for inquiries that concern Dragotakes Consulting by calling the company number (508) 359-7214, as your correspondence is most welcome. Additionally, the physical location of the single location of Dragotakes Consulting can be found at the coordinates 42.187865,-71.287294 as well as the street address 18 Hillcrest Road in Medfield, Massachusetts 02052.
For its online presence, you may visit Dragotakes Consulting’s website at and engage with its social media outlets through on Twitter and on Facebook.